Nektar Therapeutics (NASDAQ:NKTR)

11.89
Delayed Data
As of Jul 02
 -0.23 / -1.90%
Today’s Change
9.51
Today|||52-Week Range
17.53
-23.29%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 17.00, with a high estimate of 19.00 and a low estimate of 13.00. The median estimate represents a +42.98% increase from the last price of 11.89.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.40
Sales
$21.2M
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -259.33%
 
 
 
 
 
 
Growthannually -26.19%
 
 
 
 
 
 

Sales

Growthquarterly -80.56%
 
 
 
 
 
 
Growthannually 14.76%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account